Hepatocyte growth factor activator inhibitor type 1 (HAI-1) is required for branching morphogenesis in the chorioallantoic placenta

Molecular and Cellular Biology

Volumn 25, Issue 13, 2005, Pages 5687-5698

  Tanaka, Hiroyuki ^a   Nagaike, Koki ^a   Takeda, Naoki ^b   Itoh, Hiroshi ^a   Kohama, Kazuyo ^a   Fukushima, Tsuyoshi ^a   Miyata, Shiro ^a   Uchiyama, Shuichiro ^a   Uchinokura, Shunro ^a   Shimomura, Takeshi ^c   Miyazawa, Keiji ^d   Kitamura, Naomi ^e   Yamada, Gen ^b   Kataoka, Hiroaki ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

^e TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATOCYTE GROWTH FACTOR ACTIVATOR INHIBITOR TYPE 1; MATRIPTASE; MEMBRANE PROTEIN; MESSENGER RNA; SCATTER FACTOR; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRANCHING MORPHOGENESIS; CELL PROLIFERATION; CHORIOALLANTOIS; CONTROLLED STUDY; CYTOTROPHOBLAST; EMBRYO; EMBRYO DEVELOPMENT; EPITHELIUM CELL; FEMALE; GENE; GENETIC RECOMBINATION; GIANT CELL; GROWTH RETARDATION; HAI 1 GENE; HETEROZYGOSITY; HISTOLOGY; HOMOZYGOSITY; IN VIVO STUDY; LETHALITY; MOUSE; MUTANT; NONHUMAN; PLACENTA DEVELOPMENT; PLACENTA INSUFFICIENCY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CHORIOALLANTOIC MEMBRANE; EMBRYO LOSS; FEMALE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE TARGETING; HOMOZYGOTE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; MORPHOGENESIS; PLACENTA; PREGNANCY; RECOMBINATION, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS;

EID: 20744448360     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.25.13.5687-5698.2005     Document Type: Article

References (42)

1. Adams, R. H., A. Porras, G. Alonso, M. Jones, K. Vintersten, S. Panelli, A. Valladares, L. Perez, R. Klein, and A. R. Nebreda. 2000. Essential Role of p38a MAP kinase in placental but not embryonic cardiovascular development. Mol. Cell 6:109-116.
2. Anson-Cartwright., L., K. Dawson, D. Holmyard, S. J. Fisher, R. A. Lazzarini, and J. C. Cross. 2000. The glial cells missing-1 protein is essential for branching morphogenesis in the chorioallantoic placenta. Nat. Genet. 25:311-314.
3. Baczyk, D., A. Satkunaratnam, B. Nait-Oumensmar, B. Huppertz, J. C. Cross, and J. C. P. Kingdom. 2004. Complex patterns of GCM1 mRNA and protein in villous and extravillous trophoblast cells of the human placenta. Placenta 25:553-559.
4. Barak, V., M. C. Nelson, E. S. Ong, Y. Z. Jones, P. Ruiz-Lozano, K. R. Chien, A. Koder, and R. M. Evans. 1999. PPARγ required for placental, cardiac, and adipose tissue development. Mol. Cell 4:585-595.
5. Bladt, F., D. Reithmacher, S. Isenmann, A. Aguzzi, and C. Birchmeier. 1995. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 376:768-771.
6. Colosi, P., F. Talamantes, and D. I. Linzer. 1987. Molecular cloning and expression of mouse placental lactogen I complementary deoxyribonucleic acid. Mol. Endocrinol. 1:767-776.
7. Ihle, J. N. 2000. The challenges of translating knockout phenotype into gene function. Cell 102:131-134.
8. Itoh, H., H. Kataoka, J. Y. Meng, R. Hamasuna, N. Kitamura, and M. Koono. 2001. Mouse hepatocyte growth factor activator inhibitor type 1 (HAI-1) and type 2 (HAI-2)/placental bikunin genes and their promoters. Biochem. Biophys. Acta 1519:92-95.
9. Itoh, H., H. Kataoka, M. Tomita, R. Hamasuna, Y. Nawa, N. Kitamura, and M. Koono. 2000. Upregulation of HGF activator inhibitor type 1 but not type 2 along with regeneration of intestinal mucosa. Am. J. Physiol. Gastrointest. Liver Physiol. 278:G635-G643.
10. Itoh, H., S. Naganuma, N. Takeda, S. Miyata, S. Uchinokura, T. Fukushima, S. Uchiyama, H. Tanaka, K. Nagaike, T. Shimomura, K. Miyazawa, G. Yamada, N. Kitamura, M. Koono, and H. Kataoka. 2004. Regeneration of injured intestinal mucosa is impaired in hepatocyte growth factor activator-deficient mice. Gastroenterology 127:1423-1435.
11. Kataoka, H., J. Y. Meng, H. Itoh, R. Hamasuna, T. Shimomura, T. Suganuma, and M. Koono, 2000. Localization of hepatocyte growth factor activator inhibitor type 1 in Langhans' cells of human placenta. Histochem. Cell Biol. 114:469-475.
12. Kataoka, H., R. Hamasuna, H, Itoh, N. Kitamura, and M. Koono. 2000. Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma. Cancer Res. 60:6148-6159.
13. Kataoka, H., S. Miyata, S. Uchinokura, and H. Itoh. 2003. Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor. Cancer Metastasis Rev. 22: 223-236.
14. Kataoka, H., T. Shimomura, T. Kawaguchi, R. Hamasuna, H. Itoh, N. Kitamura, K. Miyazawa, and M. Koono. 2000. Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator(HGFA) and regulates HGFA activity in the pericellular microenvironment. J. Biol. Chem. 275:40453-40462.
15. Kataoka, H., T. Suganuma, T. Shimomura, H. Itoh, N. Kitamura, K. Nabeshima, and M. Koono. 1999. Distribution of hepatocyte growth factor activator inhibitor type 1 (HAI-1) in human tissues: cellular surface localization of HAI-1 in simple columnar epithelium and its modulated expression in injured and regenerative tissues. J. Histochem. Cytochem. 47:673-682.
16. Kaufmann, M. H. 1992. Differentiation of the placenta, p. 472-477. In M. H. Kaufmann (ed.), The atlas of mouse development, 6th ed. Academic Press, Inc., New York, N.Y.
17. Kawaguchi, T., L. Qin, T. Shimomura, J. Kondo, K. Matsumoto, K. Denda, and N. Kitamura. 1997. Purification and cloning of hepatocyte growth factor activator inhibitor type 2, a Kunitz-type serine protease inhibitor. J. Biol. Chem. 272:27558-27564.
18. Kirchhofer, D., M. Peek, W. Li, J. Stamos, C. Eigenbrot, S. Kadkhodayan, J. M. Elliot, R. T. Corpuz, R. A. Lazarus, and P. Moran. 2003. Tissue expression, protease specificity, and Kunitz domain functions of hepatocyte growth factor activator inhibitor-1B (HAI-1B), a new splice variant of HAI-1. J. Biol. Chem. 278:36341-36349.
19. Lee, S. L., R. B. Dickson, and C. Y. Lin. 2000. Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J. Biol. Chem. 275:36720-36725.
20. Lescin, K. R., S. Varmuza, and J. Rossant. 1988. Isolation and characterization of a novel trophoblast-specific cDNA in the mouse. Genes Dev. 2:1639-1646.
21. Lin, C. Y., J. Anders, M. Johnson, and R. B. Dickson. 1999. Purification and characterization of a complex containing matriptase and a Kunitz-type serine protease inhibitor from human milk. J. Biol. Chem. 274:18237-18242.
22. Lin, C. Y., J. Anders, M. Johnson, Q. A. Sang, and R. B. Dickson. 1999. Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity. J. Biol. Chem. 274:18231-18236.
23. List, K., C. C. Haudenschild, R. Szabo, W. J. Chen, S. M. Wahl, W. Swaim, L. H. Engelholm, N. Behrend, and T. H. Bugge. 2002. Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis. Oncogene 21:3765-3779.
24. List, K., R. Szabo, P. W. Wertz, J. Segre, C. C. Haudenschild, S. Y. Kim, and T. H. Bugge. 2003. Loss of proteolytically processed filaggrin caused by epidermal deletion of Matriptase/MT-SP1. J. Cell Biol. 163:901-910.
25. Mitchell, K. J., K. I. Pinson, O. G. Kelly, J. Brennan, J. Zupicich, P. Scherz, P. A. Leighton, L. V. Goodrich, X. Lu, B. J. Avery, P. Tate, K. Dill, E. Pangilian, P. Wakenight, M. Tessier-Lavigne, and W. C. Skarnes. 2001. Functional analysis of secreted and transmembrane proteins critical to mouse development. Nat. Genet. 28:241-249.
26. Miyazawa, K., T. Shimomura, A. Kitamura, J. Kondo, Y. Morimoto, and N. Kitamura. 1993. Molecular cloning and sequence analysis of the cDNA for a human serine protease responsible for activation of hepatocyte growth factor. J. Biol. Chem. 268:10024-10028.
27. Miyazawa, K., T. Shimomura, and N. Kitamura, 1996. Activation of hepatocyte growth factor in the injured tissues is mediated by hepatocyte growth factor activator. J. Biol. Chem. 271:3615-3618.
28. Moser, M., Y. Li, K. Vaupel, D. Kretzschmar, R. Kluge, P. Glynn, and R. Buettner. 2004. Placental failure and impaired vasculogenesis result in embryonic lethality for neuropathy target esterase-deficient mice. Mol. Cell. Biol. 24:1667-1679.
29. Nagaike, K., K. Kohama, S. Uchiyama, H. Tanaka, K. Chijiiwa, H. Itoh, and H. Kataoka. 2004. Paradoxically enhanced immunoreactivity of hepatocyte growth factor activator inhibitor type 1(HAI-1) in cancer cells at the invasion front. Cancer Sci. 95:728-735,
30. Oberst, M. D., C. A. Williams, R. B. Dickson, M. D. Johnson, and C. Y. Lin. 2003. The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor. J. Biol. Chem. 278:26773-26779.
31. Pavek, P., F. Staud, Z. Fendrich, H. Sklenarova, A. Libra, M. Novotna, M. Kopecky, M. Nobilis, and V. Semecky. 2003. Examination of the functional activity of P-glycoprotein in the rat placental barrier using rhodamine 123. J. Pharmacol. Exp. Ther. 305:1239-1250.
32. Pötgens, A. J. G., H. Kataoka, S. Ferstl, H. G. Frank, and P. Kaufmann. 2003. A positive immunoselection method to isolate villous cytotrophoblast cells from first trimester and term placenta to high purity. Placenta 24:412-423.
33. Roberts, R. M., T. Ezashi, and P. Das. 2004. Trophoblast gene expression: Transcription factors in the specification of early trophoblast. Reprod. Biol. Endocrinol. 2:1-9.
34. Rossant, J., and J. C. Cross. 2001. Placental development: lessons from mouse mutants. Nat. Rev. Genet. 2:538-548.
35. Schmidt, C., F. Bladt, S. Goedecke, V. Brinkmann, W. Zschiesche, M. Sharpe, E. Gherardi, and C. Birchmeler. 1995. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373:699-702.
36. Schreiber, J., E. Riethmacher-Sonnenberg, D. Riethmacher, E. E. Tuerk, J. Enderich, M. R. Bösl, and M. Wegner. 2000. Placental failure in mice lacking the mammalian homolog of glial cell missing, GCMa. Mol. Cell. Biol. 20:2466-2474.
37. Shimomura, T., K. Denda, A. Kitamura, T. Kawaguchi, M. Kito, J. Kondo, S. Kagaya, L. Qin, H. Takata, K. Miyazawa, and N. Kitamura. 1997. Hepatocyte growth factor activator inhibitor, a novel Kunitz-type serine protease inhibitor. J. Biol. Chem. 272:6370-6376.
38. Takeuchi, T., J. L. Harris, W. Huang, K. W. Yan, S. R. Coughlin, and C. S. Craik. 2000. Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J. Biol. Chem. 275:26333-26342.
39. Uehara, Y., O. Minowa, C. Mori, K. Shiota, J. Kuno, T. Noda, and N. Kitamura. 1995. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 373:702-705.
40. Voss, A. K., T. Thomas, and P. Gruss. 2000. Mice lacking HSP90βfail to develop a placental labyrinth. Development 127:1-11.
41. Yagi, T., T. Tokunaga, Y. Furata, S. Nada, M. Yoshida, T. Tsukuda, Y. Saga, N. Takeda, Y. Ikawa, and S. Aizawa. 1993. A novel ES cell line, TT2, with high germline-differentiating potency. Anal. Biochem. 214:70-76.
42. Zhang, Y. W., and G. F. Vande Wounde. 2003. HGF/SF-Met signaling in the control of branching morphogenesis and invasion. J. Cell Biochem. 88:408-417.